Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 1711 2911 460
Operating income (EBITDA)161231289324365418
Operating profit (EBIT)120185-272306376
Pre-Tax Profit (EBT)105170-259294351
Net income72,5139177181207252
P/E ratio34,239,031,228,925,721,1
EPS ( € )0,791,511,922,032,282,79
Dividend per Share ( € )0,220,33-0,450,670,55
Yield0,81%0,56%-0,76%1,15%0,94%
Reference price ( € )26.883358.959.9758.6558.6558.65
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,4-4,35--
Finance----68,7-
Operating income (EBITDA)161231289324365418
Leverage
(Debt/EBITDA)
0,54x0,37x-0,01x--
Capital Expenditure47,153,0-96,7100105
Book Value Per Share (BVPS)5,78 €6,96 €-10,1 €12,0 €14,7 €
Cash Flow per Share1,21 €1,52 €-2,44 €2,72 €3,20 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 5 406 M€ -
Entreprise Value (EV) 5 411 M€ 5 338 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 28,9x 25,7x
Capitalization / Revenue 4,62x 4,19x
EV / Revenue 4,62x 4,13x
EV / EBITDA 16,7x 14,6x
Yield (DPS / Price) 0,76% 1,15%
Price to book (Price / BVPS) 5,80x 4,87x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 23,3% 23,7%
operating Leverage (Delta EBIT / Delta Sales) - 1,21x
Net Margin (Net Profit / Revenue) 15,4% 16,0%
ROA (Net Profit / Asset) 12,8% 13,3%
ROE (Net Profit / Equities) 20,6% 19,6%
Rate of Dividend 21,9% 29,6%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   8,26% 7,77%
Cash Flow / Sales 19,2% 19,4%
Capital Intensity (Assets / Sales) 1,20x 1,20x
Financial Leverage (Net Debt / EBITDA) 0,01x -0,19x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend